PERCEPTIVE ADVISORS LLC
Q1 2021 13F-HR/A Holdings
Net value change ($000)
-1,410,550
(-15.1%)
New positions
30
Sold out positions
33
Turnover %
20.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Landos Biopharma, Inc. | 140,967 | NEW |
| ALDX | 60,284 | 139.8% |
| Prometheus Biosciences, Inc. | 55,354 | NEW |
| AVIR | 54,790 | 42.2% |
| SpringWorks Therapeutics, Inc. | 53,840 | 17.8% |
| EXAS | 46,587 | NEW |
| VYNE | 46,368 | NEW |
| MORPHIC HLDG INC | 43,026 | 263.3% |
| MGNX | 39,588 | 137.3% |
| BEAM | 37,832 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| FOLD | -353,967 | -61.0% |
| Mirati Therapeutics, Inc. | -216,061 | -26.6% |
| IOVA | -151,401 | -35.6% |
| NVAX | -116,305 | -100.0% |
| Invitae Corp | -99,732 | -32.7% |
| KRRO | -94,855 | -82.5% |
| Athenex, Inc. | -92,339 | -61.7% |
| NBIX | -90,447 | -49.7% |
| Eidos Therapeutics, Inc. | -90,385 | -100.0% |
| ZYMEWORKS INC | -66,496 | -32.7% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
384,045
(4.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|